Background. The International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification represents the gold standard for the histological evaluation of Systemic Lupus Erythematosus (SLE) nephritis. A repeat biopsy (RB) might be an important tool to provide information on long-term renal outcomes and optimal therapy. Aims of this study were to evaluate the use of the ISN/RPS classification and the role of RB in routine clinical practice. Methods. A total number of 142 patients with SLE nephritis and with adequate reference and RB samples were included in this multicentre retrospective study. A meticulous histological examination was centrally performed on first and RB and compared with clinical variables and follow-up data.
I N T RO D U C T I O N
The International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification represents the gold standard for the histological evaluation of Systemic Lupus Erythematosus glomerulonephritis (SLE GN) [1] [2] [3] . In this classification, diagnostic terminology has been clearly defined, making histological diagnosis more reproducible; as a result, differences among renal pathologists are expected to decrease. ISN/RPS Class III identifies focal segmental GN with necrotizing lesions; Class IV is divided into global (IV-G) and segmental (IV-S) forms. Whether morphological differences are an expression of different pathogenetic mechanisms with different clinical features is still debated and its understanding may provide beneficial information to predict long-term renal outcomes and to identify optimal therapy to prevent end-stage renal failure [4] [5] [6] . A repeat biopsy (RB) might be an important tool to study clinical and pathological aspects of SLE GN. Nowadays, there is a scarcity of data on RB in SLE patients, even if current guidelines strongly recommend it [7] [8] [9] . Histological features at RB have been reported to correlate with improved diagnostic predictive values, while serology, creatinine levels and activity indices show a modest relation [10, 11] . Moreover, recent studies on RB in adult and children demonstrated that a second biopsy during a flare or at the end of maintenance phase of therapy could guide physicians to safer practices with improved results [12] [13] [14] [15] . Enrolling a large number of patients diagnosed with SLE GN, the current international multicentre study aimed at evaluating the use of ISN/RPS classification and the role of RB in routine practice. Furthermore, this paper provides an overview of the most important findings in this compound field of nephropathology, matching meticulous morphological data and clinical variables.
M AT E R I A L S A N D M E T H O D S

Patients
This retrospective multicentre study included data on 142 patients with a histological diagnosis of SLE nephritis between 1969 and 2006, who were subsequently subjected to RB. Patients were eligible if they had SLE, as defined by the European League Against Rheumatism (EULAR [7] ), and had a positive biopsy for SLE GN. In addition, adequate biopsy samples containing >10 glomeruli were required for inclusion. Thus, 37 SLE nephrites were excluded due to the absence of enough glomeruli or inconclusive histopathological results. Patients were enrolled at the following centres: Nephropathology Centre San Gerardo Hospital (n = 25), San Carlo Borromeo Hospital (n = 23), Policlinico Ca' Granda Hospital (n = 23), Kitano Hospital (n = 22), Sendai Shakaihoken Hospital (n = 15), Clinic Barcelona Hospital (n = 14); University of Antioquia (n = 7), St Vincent's Hospital (n = 7), Manzoni Hospital (n = 4) and San Martino Hospital (n = 2). Proteinuria, serum creatinine and blood pressure levels were registered in 96 patients (67.7%) at the time of the first biopsy, 87 patients (61.3%) at RB and 79 (55.6%) during the follow-up visit. Patients were treated according to single institutional guidelines. Most often, Class III and IV SLE nephritis received induction therapy with corticosteroids and cyclophosphamide. Cyclophosphamide and mycophenolate mofetil were administered in the maintenance phase of therapy [16] .
Histopathology
All histological diagnoses (reference and RB) were centrally reviewed at the Nephropathology Centre of the San Gerardo Hospital, according to a well-accepted international form already employed in previous international trials on SLE GN [17] . Two renal pathologists (F.F., F.P.), unaware of patients' clinical data, evaluated the biopsies according to the ISN/RPS classification. The scoring system of Pollak (Austin modified) for activity and chronicity was also calculated [18] . For every case, the histological slides included haematoxylin and eosin, periodic acid-Schiff (PAS), Masson trichrome and periodic acid methenamine silver stains for light microscopy. The following histological parameters were examined in each renal biopsy: (i) glomeruli: mesangial proliferation, endocapillary proliferation, extracapillary proliferation, tuft necrosis, wire loops, glomerular sclerosis; (ii) interstitium: inflammatory infiltrates, fibrosis; (iii) tubules: atrophy, necrosis, intraepithelial infiltrates. The study analysed exclusively morphological data; however, immunofluorescence (IgG, IgA, IgM, C3, C1q, fibrinogen, kappa and lambda light chains) was always performed for central diagnosis confirmation. Electron microscopy results were available in 80 first biopsies and 55 RBs for additional verification.
Statistical analysis
Descriptive analyses were performed on the histological and clinical data collected at first and RB, and also on followup information. Cohen's weighted kappa was used to calculate the agreement between the ISN/RPS classification at the two biopsies. For the comparisons of selected histological and clinical characteristics in Class IV-G versus IV-S and versus III, the Wilcoxon-Mann-Whitney test and the Fisher exact test were utilized for continuous and categorical variables, respectively. All tests were two-sided with a significance level of 0.05.
R E S U LT S
Patients' characteristics Patients were more commonly female (n = 125, 88%) and the mean age at the reference biopsy was 29.8 years (standard deviation [SD] = ±10.3). The first biopsy mean time after SLE diagnosis was 1.2 years (SD = ±2.8), with a mean interval between the first and the RB of 4.9 years (SD = ±4.9). In 51 out of 142 patients (36%), the RB was performed during a quiescent phase of the disease to evaluate a possible reduction of immunosuppressive therapy. In 19 patients (13.3%), the indication for RB was persistent non-nephrotic proteinuria, in 32 patients (22.5%) nephrotic syndrome, while the remaining 40 patients (28.2%) experienced a significant worsening of the renal function or an acute renal failure.
ISN/RPS classification at first and RB
The distribution of the ISN/RPS classes at first and RB, and the transitions from one class to the other are shown in Table 1 . Class IV was the most represented both at first (50.7%) and RB (41.5%), with the majority of patients belonging to IV-G (40.8 and 36.5%, respectively). Eighty-four out of the 142 patients (59.2%) did not change class when the RB was evaluated; Classes IV-G and V showed the most stable behaviour, with more than 70% of the patients remaining in the same class. The moderate level of agreement between the ISN/ RPS classification at first and RB is reflected by a weighted Cohen's index of 0.48 (95% CI: 0.37-0.59). Among the reclassified patients, the transitions between Classes II and IV-G, and between III and IV-S are of particular interest. Fifty per cent of patients in Class II switched to Class IV-G at RB, while 18.9% in Class IV-G were reclassified as Class II. Three patients in Class III (20%) evolved in Class IV-S, and 35.7% included in Class IV-S were reclassified as Class III. Tables 2 and 3 show the main histological characteristics of the glomerular tufts on first and RB (Figures 1 and 2 ). As expected, a moderate or severe mesangial proliferation was observed in almost all Class IV-G patients ( Figure 1E ), while it was less expressed in Class IV-S (94.8 versus 35.7%, P = 0.0001 and 90.3 versus 57.1%, P = 0.0077 at reference and RB, respectively). Endocapillary and extracapillary proliferation did not differ in Classes III, IV-S and IV-G, even if severe endocapillary proliferation was poorly represented in Class III. Tuft necrosis was more often noted in IV-S patients ( Figure 1C ) than in IV-G cases (42.8 versus 6.8%, P = 0.0026 and 42.8 versus 1.9%, P = 0.0041 at first and RB, respectively). The presence of wire loops decreased from Classes IV-G to III through IV-S. The comparison of Class IV-G and IV-S at first biopsy was statistically significant (75.9 versus 14.3%, P = 0.0001), while at RB the difference was attenuated and of borderline significance, probably due to the small number of patients in IV-S class (63.4 versus 28.5%, P = 0.1087). Wire loops were almost absent in Class III. The distribution of segmental (ranging from 20 to 24.1%) and global sclerosis (ranging from 35.7 to 46.6%) was similar in the three classes at first biopsy, while segmental sclerosis was more represented in Class III (70.6%) and global sclerosis in Class IV-G (73%) at RB. Tables 4 and 5 show the histological differences in the interstitial lesions on the first and RB, respectively. Interestingly, on first biopsy, tubulitis was not differently expressed in the three proliferative classes, ranging from 16 to 36%. On RB, no infiltrate or tubulitis was found in Class III and IV-S patients, differently from Class IV-G patients where infiltrates and tubulitis were present in the 33 and 25% of cases, respectively. The interstitial fibrosis, which was similar on the first biopsy in the three classes (ranging from 7.1 to 17.2%), increased in Class IV-G (57.7%) and in IV-S (28.6%) on RB. The mean value of the Pollak-Austin chronicity index at first biopsy was significantly higher in Class IV-G (1.81) than in Classes III (1.3) and IV-S (0.13; P = 0.0317 and P = 0.0182, respectively). At RB, this index was >3 in all classes, with a peak of 3.93 for IV-G (Table 5) . On the contrary, the activity index showed a more stable behaviour in the two biopsy occasions.
Histopathology at first and RB
ISN/RPS classification and clinical features at first and RB
As shown in Table 6 , at first biopsy, we observed a higher serum creatinine mean value in Class IV-G (1.4 mg/dL) than in Classes III (0.8 mg/dL) and IV-S (1.0 mg/dL; P = 0.0152 and P = 0.2823, respectively). The same trend was observed at RB. The mean value of proteinuria at first renal biopsy was not different in Classes III (2.3 g/day) and IV-S (2.3 g/ day), while it increased to 4.1 g/day in Class IV-G; similar Results are reported as n and (%). The percentages shown in total are calculated on the overall sample of 142 patients, while those in the body of the table describe the percentage distribution of the RB reclassification in each class at first biopsy.
findings were noted at RB. Arterial hypertension at first biopsy tended to be more common in Class IV-G than in IV-S (45.7 versus 0%, P = 0.0698). The highest prevalence of hypertension in Class IV-G (59.5%) was confirmed at RB. These data indicate more severe renal damage in Class IV-G both at first and RB. Results are reported as n and (%). Results are reported as n and (%). a
Significant test for the comparison of class IV-G versus IV-S.
O R I G I N A L A R T I C L E S L E n e p h r i t i s h i s t o p a t h o l o g y a n d R B
ISN/RPS classification and follow-up clinical features
The average interval between RB and final follow-up was 7.7 years. ISN/RPS classification at first biopsy did not successfully stratify patients (Table 7) , as the mean serum creatinine at follow-up was similar in patients classified as IV-S (2.1 mg/ dL) and IV-G (2.3 mg/dL). A more accurate clinical and prognostic indication came from RB values, as IV-G class patients had worst mean serum creatinine (2.8 mg/dL) compared with IV-S (0.8 mg/dL). High mean creatinine (2 mg/dL) and proteinuria levels (2.5 g/day) were observed at follow-up in patients classified as Class II at first biopsy. These values decreased in patients who had a Class II diagnosis at RB (0.9 mg/dL and 0.3 g/day, respectively).
D I S C U S S I O N
Up to date, the 2003 ISN/RPS classification is considered the gold standard for the histological evaluation of SLE GN [1] [2] [3] . This classification introduced several important quantitative and qualitative differences between Class III, IV-S and IV-G lesions. To our knowledge, this multicentre collaboration included one of the largest cohorts of patients who underwent RB for SLE GN, offering the opportunity to evaluate the ISN/RPS classification in routine practice and to test the predictive value of RB in the management of disease. The study was designed to have the morphological evaluation of the original slides centrally 
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S L E n e p h r i t i s h i s t o p a t h o l o g y a n d R B 3019 performed by two experienced renal pathologists in a highly specialized nephropathology centre. Different studies have shown pathological and clinical differences between IV-S and IV-G classes. The vast majority suggested that IV-S and IV-G subclasses do not represent a simple continuum of disease; nevertheless, these findings were based on limited samples of patients and follow-up [19, 20] . Overall, patients with Class IV-G lesions had greater subendothelial deposits on immunofluorescence, and were characterized by wire loops and hyaline deposits on light microscopy. Conversely, Class IV-S showed predominant mesangial deposits and a higher rate of glomerular fibrinoid necrosis of viable glomeruli. Other differences included the presence of membranoproliferative features only in Class IV-G lesions [21] . We observed that focal (III) and diffuse segmental (IV-S) glomerular lesions were characterized by segmental endocapillary proliferation, fibrin deposition, intense inflammatory lesion with karyorrhexis, basement membrane wall destruction and crescents ( Figures 1A, C and 2A-D) , while the presence of severe mesangial proliferation and wire loops was glomerular characteristics strictly related to IV-G patients ( Figures 1E and  2E and F) . The segmental lesions showing necrosis were similar to the lesions of systemic vasculitis [22] , suggesting a possible Table 5 . Interstitial lesions and activity/chronicity indices overall and by ISN/RPS classes at RB Mean chronicity index (SD)
Results are reported as n and (%), unless otherwise specified. Table 4 . Interstitial lesions and activity/chronicity indices overall and by ISN/RPS classes at first renal biopsy Results are reported as n and (%), unless otherwise specified. § statistically significant test for the comparison of class III vs IV-S. *statistically significant test for the comparison of class IV-G vs IV-S. 
S L E n e p h r i t i s h i s t o p a t h o l o g y a n d R B role of cellular immunity in the pathological process of these cases. This hypothesis is different from the generally accepted theory of immune complex deposition in SLE GN. The similarity of the segmental proliferative lesions to anti-neutrophil cytoplasmic antibodies (ANCA)-related GN suggests also a possible aetiological role of ANCA in SLE GN. It has been reported that 15-20% of patients with SLE have detectable ANCAs [23, 24] . Moreover, our personal experience with a previous histological series of SLE nephritis cases (data not published) seemed to confirm a different intraglomerular infiltration of monocyte/macrophages between segmental (Classes III and IV-S) and global forms (IV-G, Figure 1B, D snd F) . Future studies will probably clarify the role of these inflammatory populations in the pathogenesis of SLE nephritis. The evaluation of the association between ISN/RPS classification and clinical parameters confirmed the importance of the distinction between Classes III, IV-S and IV-G. Indeed, IV-G lesions had worse proteinuria, higher serum creatinine and blood pressure levels than Classes III and IV-S, both at first and RB. Moreover, RB might be an important tool to study clinical and pathological aspects of SLE GN. Histological features at RB have been reported to correlate with improved diagnostic predictive values [10, 11] . At RB, we found that transitions from segmental (Classes III and IV-S) to global (IV-G) or mesangial forms (Class II) were very rare. Moreover, in the mixed class, we did not observe any shift among the segmental (V + III and V + IV-S) and global forms (V + IV-G), or vice versa. On the contrary, we described reciprocal changes between Classes III and IV-S. Probably due to therapy success, 18% of IV-G cases had a strong regression to Class II, whereas 50% of Class II cases had a histological progression to Class IV-G. Our RB data confirmed that III/IV-S and IV-G classes could be different entities. The changes from the first assigned class and the frequent discrepancy between reference biopsy results and clinical markers at follow-up suggest that RB might be used as an important tool in guiding physicians to safer practices. Many investigators have studied the use of RB in case of SLE nephritis flare or renal function worsening [13, 25] . Since 36% of our patients had quiescent disease at RB, one could conclude that a strategy of RB may be useful in decreasing or stopping the therapy regimens. In our study a Class II diagnosis at RB was a good prognostic indicator, while the same class at the reference biopsy was not related to good clinical follow-up data, probably due to progression to more aggressive forms. On the contrary, a RB diagnosis of IV-G was a negative factor when compared with the final follow-up. Given its retrospective nature, this study had some limitations. First of all, due to the rarity of RB in routine practice, this cohort of 142 patients with SLE and RB was obtained in an extended period of almost 40 years; therefore, some clinical data were inevitably missing. Furthermore, the authors were not able to precisely weight the correlation between different therapeutic regimens and morphological and clinical features of the RB. Thus, also considering controversial data on onetime biopsy strategy, which affirm that segmental and global subclasses could have similar renal outcomes [26] , new perspective multicentre clinical trials should be performed to possibly include RB in SLE GN management guidelines and to confirm our results.
CO N C L U S I O N S
Morphological differences between ISN/RPS classes, in particular segmental and global forms, were evident and possible expression of different pathogenetic mechanisms. The transition from one ISN/RPS class to another during the natural history of SLE GN is a frequent event, but the transition among segmental (III, IV-S) and 'mesangial' forms (II, IV-G) is very rare. An RB can be useful in monitoring the pathological evolution of the disease. Larger perspective trials, using protocol biopsies, are needed to investigate more deeply the relationship between histology and clinical data in an RB strategy.
